General Catalyst
A large venture firm founded in Cambridge, Massachusetts, that now spans seed to growth and even owns a hospital system. Its health portfolio includes the radiopharmaceutical company Alpha-9 Oncology and the radiology AI firm Aidoc.
Overview
General Catalyst was founded in 2000 by Joel Cutler and David Fialkow, is headquartered in Cambridge, Massachusetts, and has offices in San Francisco, New York, London, Berlin and Bangalore (Wikipedia). Its site describes Seed, Create (company creation) and Grow strategies, plus a Health Assurance Transformation Company that in 2024 acquired the Summa Health hospital system to build 'a blueprint for proactive, accessible, affordable American healthcare'. Oncology is a small part of a broad healthcare practice. The portfolio page lists Alpha-9 Oncology (targeted radiopharmaceuticals; Healthcare, North America) and Aidoc (AI triage for medical imaging), alongside Altos Labs and many care-delivery and health software companies.
Portfolio in OnCo (1)
Filter the startups table| Company | Stage | Type | Cancers | Latest round |
|---|---|---|---|---|
| Alpha-9 Oncology Vancouver, CA | Growth stage | radiopharma | Melanoma | Series C 2024, $175M |
Pages like this
not linked directly; found by shared links- CompanySamsara BioCapital
Shares Alpha-9 Oncology and the tag vc.
- CompanyAndreessen Horowitz Bio + Health
Shares Alpha-9 Oncology and the tag vc.
- CompanyLightspeed Venture Partners
Shares Alpha-9 Oncology and the tag vc.
- CompanyFrazier Life Sciences
Shares Alpha-9 Oncology and the tag vc.
- CompanyRA Capital Management
Shares Alpha-9 Oncology and the tag vc.